327 related articles for article (PubMed ID: 23199200)
1. Superparamagnetic iron oxide nanoparticle-based delivery systems for biotherapeutics.
Mok H; Zhang M
Expert Opin Drug Deliv; 2013 Jan; 10(1):73-87. PubMed ID: 23199200
[TBL] [Abstract][Full Text] [Related]
2. Preparation, Characterization, and In Vitro pH-sensitivity Evaluation of Superparamagnetic Iron Oxide Nanoparticle- Misonidazole pH-sensitive Liposomes.
Li B; Li B; He D; Feng C; Luo Z; He M
Curr Drug Deliv; 2019; 16(3):254-267. PubMed ID: 30426901
[TBL] [Abstract][Full Text] [Related]
3. Magnetic targeting after femoral artery administration and biocompatibility assessment of superparamagnetic iron oxide nanoparticles.
Ma HL; Qi XR; Ding WX; Maitani Y; Nagai T
J Biomed Mater Res A; 2008 Mar; 84(3):598-606. PubMed ID: 17618488
[TBL] [Abstract][Full Text] [Related]
4. Surface engineering of iron oxide nanoparticles for targeted cancer therapy.
Kievit FM; Zhang M
Acc Chem Res; 2011 Oct; 44(10):853-62. PubMed ID: 21528865
[TBL] [Abstract][Full Text] [Related]
5. Epirubicin-loaded superparamagnetic iron-oxide nanoparticles for transdermal delivery: cancer therapy by circumventing the skin barrier.
Rao YF; Chen W; Liang XG; Huang YZ; Miao J; Liu L; Lou Y; Zhang XG; Wang B; Tang RK; Chen Z; Lu XY
Small; 2015 Jan; 11(2):239-47. PubMed ID: 24925046
[TBL] [Abstract][Full Text] [Related]
6. Selective in vitro anticancer effect of superparamagnetic iron oxide nanoparticles loaded in hyaluronan polymeric micelles.
Smejkalová D; Nešporová K; Huerta-Angeles G; Syrovátka J; Jirák D; Gálisová A; Velebný V
Biomacromolecules; 2014 Nov; 15(11):4012-20. PubMed ID: 25268047
[TBL] [Abstract][Full Text] [Related]
7. Targeted extracellular vesicle delivery systems employing superparamagnetic iron oxide nanoparticles.
Zhuo Z; Wang J; Luo Y; Zeng R; Zhang C; Zhou W; Guo K; Wu H; Sha W; Chen H
Acta Biomater; 2021 Oct; 134():13-31. PubMed ID: 34284151
[TBL] [Abstract][Full Text] [Related]
8. PK11195-chitosan-graft-polyethylenimine-modified SPION as a mitochondria-targeting gene carrier.
Kim YK; Zhang M; Lu JJ; Xu F; Chen BA; Xing L; Jiang HL
J Drug Target; 2016; 24(5):457-67. PubMed ID: 26390926
[TBL] [Abstract][Full Text] [Related]
9. Biocompatible superparamagnetic core-shell nanoparticles for potential use in hyperthermia-enabled drug release and as an enhanced contrast agent.
Patil-Sen Y; Torino E; De Sarno F; Ponsiglione AM; Chhabria V; Ahmed W; Mercer T
Nanotechnology; 2020 Sep; 31(37):375102. PubMed ID: 32392545
[TBL] [Abstract][Full Text] [Related]
10. Recent advances on biocompatible and biodegradable nanoparticles as gene carriers.
Mokhtarzadeh A; Alibakhshi A; Yaghoobi H; Hashemi M; Hejazi M; Ramezani M
Expert Opin Biol Ther; 2016 Jun; 16(6):771-85. PubMed ID: 26998622
[TBL] [Abstract][Full Text] [Related]
11. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.
Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M
Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351
[TBL] [Abstract][Full Text] [Related]
12. Strategies for delivering local anesthetics to the skin: focus on liposomes, solid lipid nanoparticles, hydrogels and patches.
de Araújo DR; da Silva DC; Barbosa RM; Franz-Montan M; Cereda CM; Padula C; Santi P; de Paula E
Expert Opin Drug Deliv; 2013 Nov; 10(11):1551-63. PubMed ID: 23937107
[TBL] [Abstract][Full Text] [Related]
13. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers.
Wahajuddin ; Arora S
Int J Nanomedicine; 2012; 7():3445-71. PubMed ID: 22848170
[TBL] [Abstract][Full Text] [Related]
14. Superparamagnetic lipid-based hybrid nanosystems for drug delivery.
Millart E; Lesieur S; Faivre V
Expert Opin Drug Deliv; 2018 May; 15(5):523-540. PubMed ID: 29543082
[TBL] [Abstract][Full Text] [Related]
15. Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery.
Talelli M; Rijcken CJ; Lammers T; Seevinck PR; Storm G; van Nostrum CF; Hennink WE
Langmuir; 2009 Feb; 25(4):2060-7. PubMed ID: 19166276
[TBL] [Abstract][Full Text] [Related]
16. Delivery of Superparamagnetic Polymeric Micelles Loaded With Quercetin to Hepatocellular Carcinoma Cells.
Srisa-Nga K; Mankhetkorn S; Okonogi S; Khonkarn R
J Pharm Sci; 2019 Feb; 108(2):996-1006. PubMed ID: 30121312
[TBL] [Abstract][Full Text] [Related]
17. Recent Trends in Clinical Trials Related to Carrier-Based Drugs.
Tagami T; Ozeki T
J Pharm Sci; 2017 Sep; 106(9):2219-2226. PubMed ID: 28259767
[TBL] [Abstract][Full Text] [Related]
18. Magnetically responsive layer-by-layer microcapsules can be retained in cells and under flow conditions to promote local drug release without triggering ROS production.
Read JE; Luo D; Chowdhury TT; Flower RJ; Poston RN; Sukhorukov GB; Gould DJ
Nanoscale; 2020 Apr; 12(14):7735-7748. PubMed ID: 32211625
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: magnetic targeting.
Mojica Pisciotti ML; Lima E; Vasquez Mansilla M; Tognoli VE; Troiani HE; Pasa AA; Creczynski-Pasa TB; Silva AH; Gurman P; Colombo L; Goya GF; Lamagna A; Zysler RD
J Biomed Mater Res B Appl Biomater; 2014 May; 102(4):860-8. PubMed ID: 24458920
[TBL] [Abstract][Full Text] [Related]
20. Macrophage entrapped silica coated superparamagnetic iron oxide particles for controlled drug release in a 3D cancer model.
Ullah S; Seidel K; Türkkan S; Warwas DP; Dubich T; Rohde M; Hauser H; Behrens P; Kirschning A; Köster M; Wirth D
J Control Release; 2019 Jan; 294():327-336. PubMed ID: 30586597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
